ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 732317 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 732317; 2) Community: the network communities that were significantly associated with the response to NSC 732317; 3) Molecule: the relationships between components within communities and NSC 732317; 4) MDR: the compounds that were significantly associated with the NSC 732317.

NSC Compound Enrichment Correlation
NSC 624166 Null 0.038506707102734 0.17784156
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.038506707102734 0.44610843
NSC 645727 Carbamothioic acid, 4-chloro-3-[(1-methylethoxy) iminomethyl]-, S-(1-methylethyl) ester 0.038506707102734 0.099116652
NSC 648365 Insulin-Methotrexate conjugate 0.038506707102734 0.18992064
NSC 655748 Null 0.038506707102734 0.40423439
NSC 657561 (Z)-4-bromo-4-iodo-3-phenyl-3-buten-2-one 0.038506707102734 0.40643306
NSC 662302 Null 0.038506707102734 0.10196166
NSC 671865 Null 0.038506707102734 0.17346137
NSC 673650 4-Piperidinone, 1-methyl-2,6-bis[(2-nitrophenyl)methylene]- 0.038506707102734 0.47758775
NSC 683692 .alpha.-D-Glucopyranoside, phenylmethyl 2-acetylamino-2-deoxy- 3-O-[[2-[[2-[1-(aminocarbonyl)-4-[[5-[(1-nitro- 9-acridinyl)amino]pentyl]amino]-4-oxobutyl]amino]- 1-methyl-2-oxoethyl]amino]-1-methyl-2 0.038506707102734 0.19126636
Total:83  Current:53    [First] [Prev] [Next] [Last]